News at a glance

Ad hoc announcement

Galenica Group half-year results 2025

Galenica demonstrates pleasing growth and improves EBIT guidance

 
News

New internal appointment of General Counsel and Secretary General

Barbara Wälchli, General Counsel and Secretary General, has decided to leave Galenica at the end of 2025. With Cécile Matter as the new General Counsel and Jürg Pauli as the future Secretary General of the Board of Directors, two experienced executives from within the company are taking over the reins.

 
Story

Galenica and the invisible work behind safe medications

What does it take to ensure that only safe and effective medications reach people in Switzerland? Galenica ensures that quality standards are met – from the place of manufacture all the way to the pharmacy or hospital. In this story, you’ll find out exactly how this works and what it has to do with underfloor heating.

 
News

Yves Platel is the new President of the Association of Pharmacists of the Canton of Zurich

A pharmacist from the Galenica network assumes responsibility at association level: Yves Platel, Co-Managing Director of the Amavita pharmacy at Zurich Railway Station, was elected President of the Association of Pharmacists of Zurich (AKVZ) on 19 June 2025.

 
Ad hoc announcement

Galenica to enter the diagnostics business by acquiring Labor Team

By acquiring the Labor Team Group, Galenica is adding a leading Swiss diagnostic service provider to its healthcare network.

 
Story

Committed together – how we support social projects

Twice a year, our employees have the opportunity to cast their vote and determine the proportion of donations for social projects on the crowddonating platform “there for you”. The first round of voting in 2025 was recently completed. With our support, one of the projects directly reached the donation target.

 
News

Personnel change in the position of General Counsel

Barbara Wälchli, General Counsel and Secretary General of Galenica, will leave the company at the end of 2025. She is moving to Swisscom as General Counsel.

 
News

Christina Ruob appointed as Professor of Practice at ETH Zurich

ETH Zurich recognises Christina Ruob’s outstanding performance in practice and will award her the title of “Professor of Practice”. This prestigious appointment underscores her important role in the teaching of pharmacy.

 
 
Story

Between conveyor belts and barcode scanners: a self-­experiment in the logistics centre

What happens when an office worker dives into the world of logistics? A communications employee put it to the test and spent an evening in the Galexis logistics centre, surrounded by buzzing forklifts and countless blue boxes.

 
Ad hoc announcement

Galenica continues sales growth

Sales growth of 4.7% to CHF 1,314.

 
 
Story

A temporary site that symbolises new forms of work

Galenica’s temporary site, which we call the “Swing Space”, combines flexible working and sustainability with forward-thinking collaboration models.

 
 
Story

Megatrends: Thinking about tomorrow today

A strong healthcare system requires cooperation. Together, we can find answers to the megatrends.

 
News

​​​More responsibility for pharmacies in providing care from 2027

The revision of the Health Insurance Act (HIA) strengthens the position of pharmacies as important players in the healthcare system. The development of the around 380 pharmacies in the Galenica network shows how investments in training, infrastructure and digital solutions are already paying off today.

 
News

«Sustainability cannot be achieved on your own»

Marc Werner, CEO, explains in an interview how Galenica's network philosophy strengthens its sustainable behaviour.

 
 
News

The pharmacy is becoming the first point of contact for health issues

With long waiting times for GPs and overcrowded emergency departments, many people are looking for faster access to medical assistance. Pharmacies are playing an increasingly important role in this. Galenica shows how pharmacies can meaningfully relieve strain on our healthcare system.

 
Press release

Galenica Annual General Meeting approves all motions and elects new member of the Board of Directors

All motions of the Board of Directors approved with broad consensusNadine Balkanyi-Nordmann elected as a new member of the Board of DirectorsDividend of CHF 2.

 
Ad hoc announcement

Galenica continues to grow in 2024

With sales up 4.7% in the 2024 financial year, the Galenica Group grew strongly and generated consolidated net sales of CHF 3,921.1 million.

 
Press release

Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors

Nadine Balkanyi-Nordmann, an experienced legal, compliance and governance expert, will be recommended for election as a member of the Board of Directors at the

 
Ad hoc announcement

Galenica reports strong sales growth once again

Galenica Group sales once again performed very positively in 2024, with growth of 4.7% to CHF 3,922 million.

 
News

Galenica mourns the loss of Dr. Andreas Walde

It is with great sadness that we announce the passing of Dr. iur. Andreas Walde, a long-standing member of the Board of Directors of Galenica Ltd., following a prolonged and severe illness.

 
News

Michael Severus assumes leadership of Padma Ltd.

Michael Severus will become CEO of Padma Ltd. from January 2025. Padma Ltd. is a manufacturer of Tibetan herbal remedies.

 
News

Patrick Rindlis­bacher and Martin Reck­nagel now jointly manage Medifilm

The specialist in drug blister packaging within the Galenica network has a new management model. Patrick Rindlisbacher, the current head of Medifilm, has been co-managing Medifilm with Martin Recknagel since 1 November 2024.

 
 
News

Developing new approaches to basic care – across professions and together with patients

As part of the second edition of the “Healthcare Professionals Initiative”, around 130 professionals from the healthcare sector and 11 patients worked together to develop practical solutions for specific practical cases.

 
News

Expansion of the partnership between Cooper Consumer Health and Verfora Ltd.

Cooper Consumer Health and Verfora Ltd. are intensifying their collaboration. For several years, Verfora Ltd. has been distributing the Excilor and Oenobiol brands for Cooper Consumer Health. From 1 January 2025, former Viatris OTC products will be added to the portfolio.

 
Ad hoc announcement

Galenica increases sales growth in the third quarter

Following solid sales growth of 2.6% in the first half of 2024, Galenica grew more strongly again in the third quarter and generated net sales of CHF 2,864.

 

Shaping tomorrow's healthcare system together.

Media inquiries & contact

Are you a journalist or editor and have questions about Galenica? Get in touch with us.

Media centre

Images, videos, logos: All downloads for reuse in media reports.

Information for investors

Invest in the strongest network in the Swiss healthcare market.

Here you will find information about our share price, as well as presentations, conferences and our financial calendar.

Woman holds Tablet
Woman holds Tablet

Footer